Stay informed with the latest updates for the inheritable blood disorders community.

Industry
Sigilon Releases Study Data on Hemophilia Cell Therapy
Catalyst Reports Positive Trial Updates for Subcutaneous Therapy for…
NBDF & Community
NHF Announces New NHF-Shire Clinical Fellowship Award Recipient
NHF Announces New NHF-Shire Clinical Fellowship Award Recipient
Industry
uniQure Announces First Hemophilia B Patient Treated in Phase III Gene Therapy Trial
uniQure Announces First Hemophilia B Patient Treated in Phase…
Industry
Bayer Responds to NHF-HFA Joint Statement
Roche Announces Donation of Hemlibra® to WFH Humanitarian Aid Program
Medical
Providers: NHLBI Seeking Comment on Preliminary Hemophilia Inhibitors Measurement Protocols
Providers: NHLBI Seeking Comment on Preliminary Hemophilia…
NBDF & Community
A Priceless Experience
Travel…
Medical
ISTH Creates Bleeding Assessment Tool for Hemophilia Patients
ISTH Creates Bleeding Assessment Tool for Hemophilia Patients
Court Issues Final Judgement in Shire/Roche Patent Lawsuit
Court Issues Final Judgement in Shire/Roche Patent Lawsuit
Medical
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
Gene Therapy with Transplanted Cells Shows Promise in Hemophilia A Mice
13 Athletes Run with Team NHF in the 2019 NYC Half Marathon
13 Athletes Run with Team NHF in the 2019 NYC Half Marathon
Takeda Completes Acquisition of Shire
Takeda Completes Acquisition of Shire
Honoring Linda Gammage
Honoring Linda Gammage
7 Reasons to Support NHF
7 Reasons to Support NHF
Industry
Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial
Sangamo Announces First Patient Treated in Hemophilia B Gene Therapy Trial…
NHF Statement on Texas vs. United States Lawsuit
NHF Statement on Texas vs. United States Lawsuit